Form 4 for GEHC GE HealthCare

Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001920839-25-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2025-05-19	2025-05-15	GEHC	Bankes Jeannette	CEO, Patient Care Solutions	A - Grant	$0.00	+37.0K	37.0K	New	$0
D	2025-05-19	2025-05-15	GEHC	Bankes Jeannette	CEO, Patient Care Solutions	A - Grant	$0.00	+18.8K	18.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.01 per share	2025-05-15	A	A	30,174	$0.00	30,174	D	—	—	(F1) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. (F2) Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on May 15, 2026, and 50% will vest on May 15, 2027.
2	Common	Common Stock, par value $0.01 per share	2025-05-15	A	A	6,857	$0.00	37,031	D	—	—	(F3) Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2026, 33% will vest on September 1, 2027, and 34% will vest on September 1, 2028. (F1) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
3	Derivative	Employee Stock Option (right to buy)	2025-05-15	A	A	18,754	$0.00	18,754	D	$72.91 · — to 2035-05-15	18,754 Common Stock, par value $0.01 per share	(F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028.